1.2011年10月22日-25日，美国眼科学年会在美国佛罗里达州的奥多兰举行，图为奥多治会议中心。
（1.TheOrangeCountyConventionCenterinOrlando,Florida,playedhosttotheAmericanAcademyofOphthalmology（AAO）2011AnnualMeeting,heldOctober22to25,2011.）
${FDPageBreak}
2.今年会议的亮点是：
（1）飞秒激光辅助白内障手术被视为“重大进展”
（2）MRSA眼部感染呈上升趋势，但治疗滞后
（3）青光眼患者用药依从性差异很大
（4）眼保健医生比家庭医生有更多筋骨劳伤的苦恼
（5）白内障手术有助于阿尔茨海默氏症患者
（6）iPad有助于提高视力不佳患者的阅读能力
（2.Amongthisyearshighlights:
（1）Femtosecondlaser-assistedcataractsurgeryisseenasa“majoradvance”
（2）MRSAeyeinfectionsareontherise,buttreatmentislagging
（3）Medicationcomplianceinpatientswithglaucomavarieswidely
（4）Eye-carephysicianshavemoremusculoskeletalwoesthanfamilyphysicians
（5）CataractsurgeryhelpspatientswithAlzheimersdisease
（6）TheiPadimprovesthereadingabilityofpatientswithlowvision）
${FDPageBreak}
3.飞秒激光助白内障手术一臂之力
（3.FemtosecondLaser-AssistedCataractSurgeryaMajorAdvance
Astudyprovidesstrongevidenceoftheincreasedsafetyandeffectivenessoflaser-mediatedemulsificationofcataractscomparedwithphacoemulsification.Theapproachusesfemtosecondlasertechnology,whichdeliversnear-infraredlighttocreateprecisesubsurfacecutsatdepthsthataregreaterthanthosepossibleusingconventionalapproaches.StephenSlade,MD,fromSlade&BakerVisionCenterinHouston,Texas,whowasnotinvolvedinthestudy,describedthistechniqueas“thesinglemostsignificantadvancementincataractsurgeryinthelast40years.”）
${FDPageBreak}
4.Novel眼插入改善糖尿病性黄斑水肿
（4.NovelEyeInsertImprovesDiabeticMacularEdema
Anintravitrealinsertthatreleasesasustainedandcontrolledamountofthecorticosteroidfluocinoloneacetonideimprovedvisualacuityforaslongas3yearsinastudyofpatientswithdiabeticmacularedema.Thisresult“isparticularlyexciting,asitdemonstratesthatasingleinsertcanproviderapidandsustainedimprovementinvisualacuityforupto36months,”saidDavidBrown,MD,fromRetinalConsultantsofHouston,MethodistHospital,Texas,duringhispresentation.）
${FDPageBreak}
5.视网膜中央静脉阻塞1年新药物可维持视力
（5.NewDrugMaintainsVisualAcuityinCentralRetinalVeinOcclusionat1Year
PatientswithmacularedemacausedbycentralretinalveinocclusionwhoreceivedinjectionsofVEGFTrap-Eye（RegeneronPharmaceuticals）onanas-neededbasisafterreceivingthedrugonceamonthfor6monthsmaintainedtheirinitiallyimprovedvisualacuity,accordingto1-yearresultsoftheCOPERNICUStrial.“Thisisgoodinformation.VEGFTrap-Eyeworksandappearstohavesomedurabilityofeffectwhengivenonanas-neededbasis,”saidstudypresenterJuliaHaller,MD,ophthalmologist-in-chiefattheWillsEyeInstituteandprofessorandchairoftheDepartmentofOphthalmologyatThomasJeffersonUniversityinPhiladelphia,Pennsylvania.）
（责任编辑：jbwq）
